Bodal Chemicals Ltd
Bodal Chemicals Limited is one of India’s leading integrated Dyestuff companies and is the largest domestic manufacturer of Dye Intermediates. It offers a wide range of Dyestuffs, Dye Intermediates, Basic Chemicals, and its variants to diverse customers across India and the world. [1]
- Market Cap ₹ 861 Cr.
- Current Price ₹ 68.4
- High / Low ₹ 101 / 65.8
- Stock P/E 538
- Book Value ₹ 86.0
- Dividend Yield 0.00 %
- ROCE 3.46 %
- ROE 1.13 %
- Face Value ₹ 2.00
Pros
- Stock is trading at 0.80 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -0.41% over past five years.
- Company has a low return on equity of 5.08% over last 3 years.
- Company might be capitalizing the interest cost
- Dividend payout has been low at 4.24% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Dyes And Pigments
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
527 | 960 | 1,043 | 908 | 1,233 | 1,142 | 1,424 | 1,375 | 1,226 | 2,055 | 1,574 | 1,395 | 1,583 | |
508 | 770 | 859 | 758 | 1,007 | 946 | 1,187 | 1,237 | 1,140 | 1,835 | 1,441 | 1,284 | 1,467 | |
Operating Profit | 20 | 189 | 184 | 150 | 226 | 196 | 236 | 138 | 87 | 220 | 133 | 111 | 116 |
OPM % | 4% | 20% | 18% | 16% | 18% | 17% | 17% | 10% | 7% | 11% | 8% | 8% | 7% |
4 | -70 | 5 | 19 | 15 | 8 | 13 | 10 | 16 | -2 | 12 | 9 | 18 | |
Interest | 40 | 47 | 27 | 12 | 9 | 5 | 9 | 19 | 17 | 29 | 41 | 54 | 69 |
Depreciation | 16 | 25 | 22 | 26 | 29 | 12 | 21 | 28 | 30 | 47 | 53 | 60 | 66 |
Profit before tax | -33 | 47 | 139 | 131 | 204 | 186 | 219 | 101 | 55 | 142 | 51 | 5 | -1 |
Tax % | -30% | 35% | 34% | 34% | 35% | 33% | 35% | 15% | 28% | 31% | 25% | -37% | |
-23 | 30 | 92 | 86 | 133 | 122 | 141 | 86 | 40 | 99 | 38 | 6 | 2 | |
EPS in Rs | -2.12 | 2.76 | 8.41 | 7.88 | 12.18 | 10.03 | 11.72 | 7.12 | 3.43 | 8.51 | 3.03 | 0.51 | 0.13 |
Dividend Payout % | 0% | 0% | 0% | 8% | 7% | 8% | 7% | 11% | 23% | 9% | 3% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 4% |
5 Years: | 0% |
3 Years: | 4% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | -17% |
5 Years: | -39% |
3 Years: | -33% |
TTM: | -82% |
Stock Price CAGR | |
---|---|
10 Years: | 8% |
5 Years: | 4% |
3 Years: | -15% |
1 Year: | -16% |
Return on Equity | |
---|---|
10 Years: | 12% |
5 Years: | 6% |
3 Years: | 5% |
Last Year: | 1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 22 | 22 | 22 | 22 | 22 | 24 | 24 | 24 | 24 | 24 | 25 | 25 | 25 |
Reserves | 13 | 43 | 135 | 213 | 341 | 673 | 805 | 907 | 957 | 1,028 | 1,053 | 1,057 | 1,058 |
364 | 397 | 234 | 143 | 151 | 181 | 171 | 257 | 454 | 676 | 760 | 904 | 836 | |
75 | 131 | 144 | 132 | 193 | 194 | 290 | 267 | 314 | 385 | 283 | 294 | 309 | |
Total Liabilities | 473 | 593 | 534 | 510 | 707 | 1,072 | 1,290 | 1,455 | 1,749 | 2,113 | 2,120 | 2,281 | 2,229 |
265 | 168 | 190 | 192 | 222 | 437 | 609 | 656 | 804 | 817 | 967 | 1,314 | 1,295 | |
CWIP | 0 | 9 | 3 | 0 | 9 | 19 | 26 | 7 | 14 | 70 | 193 | 68 | 69 |
Investments | 1 | 1 | 2 | 2 | 17 | 17 | 6 | 3 | 6 | 0 | 0 | 13 | 0 |
207 | 415 | 339 | 316 | 459 | 599 | 650 | 789 | 924 | 1,227 | 960 | 886 | 864 | |
Total Assets | 473 | 593 | 534 | 510 | 707 | 1,072 | 1,290 | 1,455 | 1,749 | 2,113 | 2,120 | 2,281 | 2,229 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
14 | 49 | 198 | 131 | 104 | 7 | 186 | 10 | -13 | -14 | 290 | 204 | |
-2 | -17 | -35 | -23 | -67 | -256 | -128 | -79 | -168 | -170 | -315 | -263 | |
-13 | -32 | -162 | -109 | -23 | 236 | -51 | 76 | 178 | 181 | 33 | 66 | |
Net Cash Flow | -1 | 1 | 0 | -1 | 14 | -13 | 7 | 7 | -3 | -3 | 8 | 7 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 61 | 86 | 69 | 67 | 56 | 91 | 85 | 121 | 139 | 105 | 97 | 100 |
Inventory Days | 60 | 72 | 43 | 57 | 60 | 59 | 86 | 91 | 141 | 141 | 119 | 139 |
Days Payable | 67 | 66 | 62 | 67 | 73 | 79 | 91 | 87 | 102 | 81 | 72 | 102 |
Cash Conversion Cycle | 55 | 92 | 50 | 58 | 43 | 71 | 79 | 124 | 178 | 165 | 144 | 137 |
Working Capital Days | 72 | 89 | 66 | 75 | 63 | 115 | 90 | 133 | 176 | 137 | 141 | 138 |
ROCE % | 2% | 39% | 39% | 35% | 46% | 27% | 24% | 11% | 5% | 12% | 5% | 3% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
18 Nov - Transcript of Q2 H1 FY25 earnings call submitted.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Nov - Bodal Chemicals Limited herewith submit Copies of News paper publication
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
14 Nov - Audio recording of investor call on financial results.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
14 Nov - Bodal Chemicals Limited herewith submit Investor presentation
-
Board Meeting Outcome for Outcome Of Board Meeting
14 Nov - Approved standalone and consolidated financial results for Q2 FY2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
-
Financial Year 2011
from bse
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jul 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Dec 2020TranscriptNotesPPT
-
Nov 2020Transcript PPT
-
Sep 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jul 2020Transcript PPT
-
Mar 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019Transcript PPT
-
Jun 2019TranscriptPPT
-
May 2019Transcript PPT
-
May 2019TranscriptNotesPPT
-
May 2019TranscriptNotesPPT
-
Mar 2019TranscriptNotesPPT
-
Mar 2019TranscriptNotesPPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Oct 2018TranscriptNotesPPT
-
Aug 2018Transcript PPT
-
Aug 2018TranscriptNotesPPT
-
Jun 2018Transcript PPT
-
Jun 2018Transcript PPT
-
May 2018TranscriptNotesPPT
-
Feb 2018Transcript PPT
-
Jan 2018TranscriptNotesPPT
-
Dec 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017Transcript PPT
-
Mar 2017TranscriptNotesPPT
-
Feb 2017TranscriptNotesPPT
-
Nov 2016TranscriptNotesPPT
-
Nov 2016Transcript PPT
-
Aug 2016TranscriptNotesPPT
-
Jun 2016TranscriptNotesPPT
-
Feb 2016TranscriptNotesPPT
Product Portfolio
The company has 200+ products in the segments of Basic Chemicals, Dye Intermediates, Dyestuffs & Chlor Alkali. The company recently added Benzene Derivatives to its product portfolio. The users of these chemicals are Textiles, Leather, Paper, Water Treatment, Home Care, Pharma & Agrochemical industries. [1]